← back to search

Jie Ni

UNSW Sydney · AU
Area of research
Cancer Research · Oncology
Research interest
Research interests include Biology, Cancer research, Apoptosis, Cell biology, Medicine, and Computational biology.
h-index
citations
1,784
works
21
NIH funding
primary concept
email

Recent publications

UV-ARTP compound mutagenesis breeding improves macrolactins production of Bacillus siamensis and reveals metabolism changes by proteomic
Journal of Biotechnology 2024cited by 14position: middledoi
[Potential of new self-crosslinked hyaluronic acid gel on the recovery of endometrium after artificial abortion: a multicenter, prospective randomized controlled trial].
PubMed 2024cited by 0position: middledoi
Macrolactin R from Bacillus siamensis and its antifungal activity against Botrytis cinerea
World Journal of Microbiology and Biotechnology 2023cited by 20position: firstdoi
The Role of AIF-1 in the Aldosterone-Induced Vascular Calcification Related to Chronic Kidney Disease: Evidence From Mice Model and Cell Co-Culture Model
Frontiers in Endocrinology 2022cited by 15position: middledoi
MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells
Journal of Oncology 2022cited by 5position: middledoi
miRTarBase update 2022: an informative resource for experimentally validated miRNA–target interactions
Nucleic Acids Research 2021cited by 1,021position: middledoi
THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
Advanced Science 2021cited by 61position: middledoi
Exosomes and breast cancer drug resistance
Cell Death and Disease 2020cited by 193position: middledoi
Pregabalin does not decrease acute pain or postoperative nausea and vomiting after hysterectomy: a meta-analysis
Journal of International Medical Research 2020cited by 14position: firstdoi
LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
Cancer Science 2018cited by 156position: middledoi
Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis
Cancer Medicine 2018cited by 88position: middledoi
Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
Cancer Medicine 2018cited by 19position: firstdoi
Upregulation of allograft inflammatory factor‑1 expression and secretion by macrophages stimulated with aldosterone promotes renal fibroblasts to a profibrotic phenotype
International Journal of Molecular Medicine 2018cited by 10position: middledoi
The expression pattern and potential functions of PHB in the spermiogenesis of Phascolosoma esculenta
Gene 2018cited by 10position: middledoi
T‐cell lymphomas associated gene expression signature: Bioinformatics analysis based on gene expression Omnibus
European Journal Of Haematology 2018cited by 4position: middledoi
PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway
Experimental Cell Research 2017cited by 33position: firstdoi
Allospecific Memory B Cell Responses Are Dependent on Autophagy
American Journal of Transplantation 2017cited by 20position: middledoi
Molecular cloning, characterization and expression analysis of metallothionein in the liver of the teleost Acrossocheilus fasciatus exposed to cadmium chloride
Environmental Toxicology and Pharmacology 2017cited by 10position: middledoi
MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes
Journal of Biological Chemistry 2016cited by 25position: firstdoi
O <sub>2</sub> and Ca <sup>2+</sup> Fluxes as Indicators of Apoptosis Induced by Rose Bengal–Mediated Photodynamic Therapy in Human Oral Squamous Carcinoma Cells
Photomedicine and Laser Surgery 2015cited by 17position: middledoi
Automated malignancy detection in breast histopathological images
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE 2012cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Leilei Zhou · Xuzhou Medical College5 papers (2017–2018)Xia Zhao · Nanjing University of Chinese Medicine5 papers (2017–2018)Rong Ma · Wake Forest University4 papers (2017–2018)Jifeng Feng · Zhejiang Cancer Hospital4 papers (2017–2018)Lian Yu · Guangxi University2 papers (2023–2024)Haixia Cao · Nantong University2 papers (2017–2018)Xingzhi Wang · Beijing Institute of Technology2 papers (2018–2022)Siwen Liu · Nanjing Medical University2 papers (2017–2018)Xingli Dong · UNSW Sydney2 papers (2020–2021)Cong-Cong Hou · Ningbo University2 papers (2017–2018)Xiaoyou Li · Nanjing Medical University2 papers (2018–2018)Jianbing Hao · Harbin Medical University2 papers (2018–2022)Peter Graham · UNSW Sydney2 papers (2020–2021)Lirong Hao · Harbin Medical University2 papers (2018–2022)Junquan Zhu · Ningbo University2 papers (2017–2018)Huizi Li · South China Agricultural University2 papers (2017–2018)Yong Li · Changsha University of Science and Technology2 papers (2020–2021)Xupeng Bai · The University of Sydney2 papers (2020–2021)Xueying Yuan · Harbin Medical University1 papers (2018–2018)Jeffrey Johnson · National Eczema Association1 papers (2012–2012)